Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: CRyPTIC. Public Health England. PHE-TB

PROVIDER: PRJEB41201 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR4814280_1.fastq.gz	Fastqsanger.gz
	ERR4814280_2.fastq.gz	Fastqsanger.gz
	ERR4814330_1.fastq.gz	Fastqsanger.gz
	ERR4814330_2.fastq.gz	Fastqsanger.gz
	ERR4814350_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 5438

Similar Datasets

Salmonella

Project description:Public Health England - Salmonella

| PRJNA248792 | ENA

Project description:Public Health England Pathogen Sequencing

| PRJNA248064 | ENA

Escherichia coli O157

Project description:Public Health England - Escherichia coli O157

| PRJNA259645 | ENA

Project description:CRyPTIC. Public Health Ontario. SeqTreat_PHO1

| PRJEB51436 | ENA

Project description:CRyPTIC. PHE. First_10k_genomes_study_set_4

| PRJEB25991 | ENA

Project description:CRyPTIC. PHE. First_10k_genomes_study_set_9

| PRJEB26001 | ENA

Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses [Luminex]

Project description:Tuberculosis (TB) remains a major public health problem and we lack a comprehensive understanding of how Mycobacterium tuberculosis (M. tb) infection impacts host immune responses. We compared, at two timepoints, the induced immune response to TB antigen, BCG and IL-1β stimulation between latently M. tb infected individuals (LTBI) and active TB patients. The immune response was stimulated using the TruCulture system with the corresponding stimulations: TB antigen, BCG, 1L1b, and the Luminex xMAP array was used to assess the cytokines expression profile of the samples.

2022-11-05 | E-MTAB-12380 | biostudies-arrayexpress

Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses

Project description:Tuberculosis (TB) remains a major public health problem and we lack a comprehensive understanding of how Mycobacterium tuberculosis (M. tb) infection impacts host immune responses. We compared, at two timepoints, the induced immune response to TB antigen, BCG and IL-1β stimulation between latently M. tb infected individuals (LTBI) and active TB patients. The immune response was stimulated using the TruCulture system with the corresponding stimulations: TB antigen, BCG, 1L1b, and the Nanostring platform was used to assess the gene expression profiles of the samples. The Nanostring platform was used to evaluate the gene expression

2022-11-05 | E-MTAB-12379 | biostudies-arrayexpress

Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses [metabolomics]

Project description:Tuberculosis (TB) remains a major public health problem and we lack a comprehensive understanding of how Mycobacterium tuberculosis (M. tb) infection impacts host immune responses. We compared, at two timepoints, the induced immune response to TB antigen, BCG and IL-1β stimulation between latently M. tb infected individuals (LTBI) and active TB patients. The immune response was assessed using the TruCulture system with a Null stimulation. samples were tested by Ultrahigh Performance Liquid Chromatography-Tandem Mass Spectroscopy (UPLC MS/MS) for a total of 696 metabolites.

2022-11-05 | E-MTAB-12381 | biostudies-arrayexpress

Comparative miRNA Expression Profiles in Individuals with Latent and Active Tuberculosis

Project description:To study the role of miRNAs in the transition from latent to active TB and to discover candidate biomarkers that may help predict TB progression, we have employed miRNA microarray expression profiling as a discovery platform to probe the transcriptome of peripheral blood mononuclear cells (PBMCs) with active TB, latent TB infection (LTBI), and healthy donors.Patients were recruited at the Shanghai Public Health Clinical Centre (Shanghai, China) from December, 2008 to May, 2009. The diagnosis of active TB was based on clinical presentation, chest radiography, and acid-fast stain of sputum smear.All the patients were HIV negative, as diagnosed by the Livzon Anti-HIV1/2 EIA Kit (Livzon Pharmaceutical Group Inc., Guangdong, China). Additional tests were also performed to detect hepatitis B virus (HBV) and hepatitis C virus (HCV) by using the Abbott AxSYM anti-HBsAg and HCV 3.0 antibody assay kit (Abbott Laboratories, Illinois) to exclude HBV- and HCV-positive patients (these 2 diseases are highly prevalent in China). Patients with a diabetes history were also excluded because diabetes could increase the risk of TB. Peripheral venous blood was drawn before treatment. Subjects with LTBI and healthy donors both without a history of clinical TB or other infectious diseases were recruited from the staff at the Shanghai Public Health Clinical Centre. TST and IGRA (T-SPOTM-BM-..TB, Oxford Immunuotec, Oxfordshire, U.K) results were used to distinguish the two groups. The LTBI group was TST-positive (TST>10 mm) and IGRA-positive while the healthy donors were TST-negative (TST<5 mm) and IGRA-negative. RNA of PBMC from 6 patients with active TB, 6 donors with Latent TB, and 3 healthy controls (total of 15 biologically independent samples) were used to perform Agilent Human miRNA (version 3) microarray , No replicates were included

2011-05-10 | E-GEOD-29190 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data